The Division of Hematologic Malignancies in the Department of Medicine at Memorial Sloan Kettering Cancer Center is seeking to recruit an exceptional academic physician and leader to serve as Chief of the Myeloma Service. The Division of Hematologic Malignancies is made up of 90 physicians in five services, including: Lymphoma, Leukemia, Myeloma, Benign Hematology and Adult Bone Marrow Transplantation. The Myeloma Service is comprised of 8 physicians, involved in clinical care as well as clinical and laboratory-based research.
The new service chief will report to the Head, Division of Hematologic Malignancies, and will have programmatic oversight and responsibility for the service and faculty. The service chief will work to shape the strategic and programmatic priorities for the service, clinical excellence, clinical operational efficiency, talent acquisition and retention, research, grant funding, professional development, mentorship and teaching. The administrative infrastructure available in the service will allow the service chief to maintain both a clinical practice and an independent research program.
At a minimum, qualified candidates should be/should have an: Nationally recognized clinician as well as a leader in clinical, translational, laboratory based or population science Extensive knowledge of the clinical care of patients with Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and related plasma cell disorders. Board-eligible or board-certified in Medical Oncology Eligible for licensure in New York State and New Jersey
Please include CV, leter of interest and names of references in your application. Please contactValentina Salkow at email@example.com or Monchell Johnson at firstname.lastname@example.org with any additional questions.
Internal Number: 2020-44475
About Memorial Sloan-Kettering Cancer Center
As one of the world's premier cancer centers, Memorial Sloan-Kettering Cancer Center is committed to exceptional patient care, leading-edge research, and superb educational programs. The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available today as we work to discover more effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan-Kettering has an impact on cancer treatment and the biomedical research agenda around the world.